Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 381

1.

Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases.

Esposito NN, Dabbs DJ, Bhargava R.

Am J Clin Pathol. 2009 Feb;131(2):228-42. doi: 10.1309/AJCP8A2UVLCYGTPU.

PMID:
19141383
2.

Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.

Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ.

Am J Surg Pathol. 2006 Aug;30(8):1002-7.

PMID:
16861972
4.

Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up.

Wynveen CA, Nehhozina T, Akram M, Hassan M, Norton L, Van Zee KJ, Brogi E.

Am J Surg Pathol. 2011 Jan;35(1):1-14. doi: 10.1097/PAS.0b013e3181fbe20a.

PMID:
21084964
5.

Encapsulated papillary carcinoma of the breast: a study of invasion associated markers.

Rakha EA, Tun M, Junainah E, Ellis IO, Green A.

J Clin Pathol. 2012 Aug;65(8):710-4. doi: 10.1136/jclinpath-2012-200710. Epub 2012 May 3.

PMID:
22554960
6.

Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?

Masood S, Loya A, Khalbuss W.

Diagn Cytopathol. 2003 Jun;28(6):329-34.

PMID:
12768640
7.

Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.

de Mascarel I, MacGrogan G, Mathoulin-Pélissier S, Soubeyran I, Picot V, Coindre JM.

Cancer. 2002 Apr 15;94(8):2134-42.

9.
10.

Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.

Dabbs DJ, Chivukula M, Carter G, Bhargava R.

Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.

12.

Breast carcinoma in women 35 years and younger: a pathological study.

Fernandopulle SM, Cher-Siangang P, Tan PH.

Pathology. 2006 Jun;38(3):219-22.

PMID:
16753742
13.

Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study.

Leal C, Costa I, Fonseca D, Lopes P, Bento MJ, Lopes C.

Hum Pathol. 1998 Oct;29(10):1097-104.

PMID:
9781648
14.

Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.

Castro NP, Osório CA, Torres C, Bastos EP, Mourão-Neto M, Soares FA, Brentani HP, Carraro DM.

Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

15.

Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.

Rakha EA, Gandhi N, Climent F, van Deurzen CH, Haider SA, Dunk L, Lee AH, Macmillan D, Ellis IO.

Am J Surg Pathol. 2011 Aug;35(8):1093-103. doi: 10.1097/PAS.0b013e31821b3f65.

PMID:
21753694
17.

Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.

Wong H, Lau S, Leung R, Chiu J, Cheung P, Wong TT, Liang R, Epstein RJ, Yau T.

Med Oncol. 2012 Sep;29(3):1536-42. doi: 10.1007/s12032-011-0082-y. Epub 2011 Oct 8.

PMID:
21983862
18.

Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study.

Iakovlev VV, Arneson NC, Wong V, Wang C, Leung S, Iakovleva G, Warren K, Pintilie M, Done SJ.

Clin Cancer Res. 2008 Jul 15;14(14):4446-54. doi: 10.1158/1078-0432.CCR-07-4960.

19.

Solid-papillary carcinoma of the breast: clinicopathological study of 20 cases.

Otsuki Y, Yamada M, Shimizu S, Suwa K, Yoshida M, Tanioka F, Ogawa H, Nasuno H, Serizawa A, Kobayashi H.

Pathol Int. 2007 Jul;57(7):421-9.

PMID:
17587241
20.

Expression of maspin is up-regulated during the progression of mammary ductal carcinoma.

Umekita Y, Yoshida H.

Histopathology. 2003 Jun;42(6):541-5.

PMID:
12786889

Supplemental Content

Support Center